Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shuke

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Cancer Research and Clinical Oncology|October 29, 1999
Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenograftsS Kinuya, K Yokoyama, H Tega, et al.
Nuclear Medicine Communications|April 4, 2002
Statistical parametric mapping in brain single photon computed emission tomography after carbon monoxide intoxicationN Watanabe, S Nohara, H Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphyN Watanabe, M Shimizu, M Kageyama, et al.
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
Japanese Journal of Cancer Research : Gann|October 10, 1998
Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude miceS Kinuya, K Yokoyama, H Tega, et al.
Cancer Letters|July 14, 1999
Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenograftsS Kinuya, K Yokoyama, T Hiramatsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancerA Chaudhry, J A Carrasquillo, I L Avis, et al.
Oncology Research|June 15, 1999
Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitorS Kinuya, K Yokoyama, W Yamamoto, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|May 1, 1996
[Pharmacokinetics of 99mTc-MAG3 and 131I-OIH: comparative study based on 2 compartment model analysis]N Shuke, T Takashio, J Sato, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 12, 1998
[Can 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) evaluate the renal function without blood sampling?: consensus report from multicenter study]A Kubo, J Hashimoto, K Nakamura, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Cancer Research and Clinical Oncology|October 29, 1999
Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenograftsS Kinuya, K Yokoyama, H Tega, et al.
Nuclear Medicine Communications|April 4, 2002
Statistical parametric mapping in brain single photon computed emission tomography after carbon monoxide intoxicationN Watanabe, S Nohara, H Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphyN Watanabe, M Shimizu, M Kageyama, et al.
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
Japanese Journal of Cancer Research : Gann|October 10, 1998
Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude miceS Kinuya, K Yokoyama, H Tega, et al.
Cancer Letters|July 14, 1999
Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenograftsS Kinuya, K Yokoyama, T Hiramatsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancerA Chaudhry, J A Carrasquillo, I L Avis, et al.
Oncology Research|June 15, 1999
Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitorS Kinuya, K Yokoyama, W Yamamoto, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|May 1, 1996
[Pharmacokinetics of 99mTc-MAG3 and 131I-OIH: comparative study based on 2 compartment model analysis]N Shuke, T Takashio, J Sato, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 12, 1998
[Can 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) evaluate the renal function without blood sampling?: consensus report from multicenter study]A Kubo, J Hashimoto, K Nakamura, et al.
Pageof 9